Lactulose Viatris (Lactulose)

Lactulose is a synthetic sugar that reaches the colon unchanged. Bacterial enzymes split it into short‑chain fatty acids, which lower colonic pH and create an osmotic gradient that draws water into the lumen. This softens stool and speeds transit, while the acidic environment traps ammonia as ammonium, decreasing systemic absorption.

The dose of Lactulose Viatris is individualized by the prescribing clinician based on the patient’s condition, age, renal function and response. Healthcare professionals determine the appropriate amount and frequency to achieve the desired therapeutic effect.

Safety data for lactulose in pregnancy and lactation are limited. It is generally considered low risk because it is minimally absorbed, but the prescriber should evaluate the benefit‑risk balance for each patient and consider alternative therapies if appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose is an osmotic laxative, differing from stimulant laxatives that increase intestinal motility. Its dual action—softening stool and lowering ammonia—makes it useful for both constipation and hepatic encephalopathy, whereas many other laxatives address only bowel movement frequency.

Lactulose Viatris should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed when not in use.

Lactulose Viatris is taken orally, usually as a liquid or syrup. The patient should follow the prescriber’s instructions regarding the amount, timing and whether it should be taken with or without food.

Serious risks include severe electrolyte disturbances such as hyponatremia, dehydration from excessive diarrhea, and rare allergic reactions. Patients should seek medical attention if they experience persistent vomiting, severe abdominal pain, or signs of an allergic response.

Lactulose is contraindicated in patients with known hypersensitivity to lactulose or any component of the formulation. Caution is advised in individuals with severe intestinal obstruction, galactosemia, or those who require strict fluid and electrolyte balance without close monitoring.